Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT) a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, today announced

It’s been a bad week for Malta’s most scarce resource: common sense. First we had MEPA chairman Andrew Calleja’s brusque (but at least honest) confession that the commodity is in short supply in the corridors of MEPA. And just as we were recovering

MOUNTAIN VIEW, Calif.----LaserCard Corporation , a leading supplier of secure ID solutions, today announced the financial results for its fiscal 2009 first quarter ended June 30, 2008.

Biophan Technologies, Inc., a developer of next-generation biomedical technology, today announced the results of their operations for the fiscal year ended February 29, 2008.

The 2nd edition of Search Engine Marketing, Inc., by experts Mike Moran and Bill Hunt, reflects the changes currently taking place in this fast-paced industry while reinforcing the solid business fundamentals of how search fits into an enterprise's overa